BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 17315600)

  • 21. Combination of anti-angiogenic therapy and virotherapy: arming oncolytic viruses with anti-angiogenic genes.
    Tysome JR; Lemoine NR; Wang Y
    Curr Opin Mol Ther; 2009 Dec; 11(6):664-9. PubMed ID: 20072943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of new drugs in angiogenesis.
    Ziche M; Donnini S; Morbidelli L
    Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
    Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
    Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pericytes: gatekeepers in tumour cell metastasis?
    Gerhardt H; Semb H
    J Mol Med (Berl); 2008 Feb; 86(2):135-44. PubMed ID: 17891366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological mechanisms of angiogenesis.
    Walsh DA
    Adv Clin Chem; 2007; 44():187-221. PubMed ID: 17682343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
    Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
    ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling pathways governing tumor angiogenesis.
    Sakurai T; Kudo M
    Oncology; 2011; 81 Suppl 1():24-9. PubMed ID: 22212932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 31. [VEGF in neoplastic angiogenesis].
    Chekhonin VP; Shein SA; Korchagina AA; Gurina OI
    Vestn Ross Akad Med Nauk; 2012; (2):23-33. PubMed ID: 22642175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.
    Goto H; Nishioka Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
    Qian CN; Tan MH; Yang JP; Cao Y
    Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pericytes: a double-edged sword in cancer therapy.
    Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
    Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin-proteasome system meets angiogenesis.
    Rahimi N
    Mol Cancer Ther; 2012 Mar; 11(3):538-48. PubMed ID: 22357635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.